By Kraig G. Fox, Founder & CEO, Reklaim Credit Solutions

A representative U.S. dispensary doing $300,000 a month in product sales receives $150,000 of inventory on 30-day terms. At month-end, after costs and taxes, can it pay that invoice? Margins and operating costs are blended composites across mature state markets; the tax illustration uses California’s structure as a representative case. Note that multi-dispensary chains likely operate more efficiently than these baseline assumptions.

Follow The Money

When a customer buys a cannabis product at a dispensary, the money they hand over begins a long, strange trip backward through the supply chain. It passes from the dispensary to the distributor, to the brand, to the manufacturer, to the cultivator, and to everyone who supplied them. This paper follows that dollar.

Here is the question this paper puts to the numbers. A dispensary receives $150,000 of inventory at the start of the month on 30-day terms, with the invoice due at month-end. It sells that product, runs its store, and meets its taxes.

When the invoice comes due, does it have the cash to pay the supplier that fronted it? We assume a store with a 50% gross margin, California’s tax structure, and blended nationwide operating costs. The central finding is stark. Once state and federal taxes are met, the store cannot fully cover the very invoice that supplied its shelves. And even if those taxes were eliminated, what is left over is razor-thin.

Because competition from the illicit and grey markets caps the prices a legal dispensary can charge, operators cannot simply raise gross margin to escape the problem. Almost every cost a dispensary carries is fixed, so when sales dip, the cost stack barely follows. This is an explanation of mechanics, not a prescription.

Start at the Register

Picture a dispensary doing about $300,000 of product sold in a month, or roughly $3.6 million a year. That is a healthy store, running roughly 24% above the typical store, which makes the squeeze that follows all the more telling: if a store performing well above average still cannot pay the invoice that stocked its shelves, the average store fares worse.

For scale, California’s market alone ran about $4.06 billion in legal retail sales in 2025 across roughly 1,412 licensed dispensaries, which works out to just under $2.9 million per store (per MJBiz Factbook 2026, California Department of Revenue).

On top of its sales, the store also collects consumer tax at the register, which it holds and remits to the state. We use a simplified, rounded 20% for that consumer tax; a representative California breakdown (a 15% excise plus combined state and local sales tax of roughly 9%) is set out in the appendix.

That tax is not the dispensary’s money. It is collected on behalf of the state and owed back, but it sits in the operator’s account for weeks before remittance.

Out of that cash, the dispensary pays for everything it takes to keep the doors open. Understanding the order and size of those payments is the whole story, because vendors, meaning the distributors and brands that supplied the product, are not first in line.

The Cost of Keeping the Lights On

Dispensary economics are well documented. Across audited financials of the largest operators, gross margin sits between roughly 45% and 55%. Operators in limited-license markets reach 58% to 62%; those in oversaturated markets compress to 38% to 42%.

For this article, I am using a 50% gross margin as a national midpoint. It is a deliberately middle-of-the-road choice: stores in saturated markets run leaner and would show a worse squeeze than the one below, so 50% is, if anything, generous to the operator.

In plain terms, somewhere between 45 and 55 cents of each retail dollar is left after paying for the product itself.

That remaining margin is then spent on operating the store.

The major categories, expressed as a share of revenue, are well understood as ranges. Labor is usually the largest at 18% to 28%. Occupancy, meaning rent and related costs, runs 8% to 15%, a premium over ordinary retail because cannabis-eligible real estate is scarce. Cannabis-specific compliance adds 3% to 6%.

Marketing runs 3% to 8%, held down by advertising restrictions.

Payment processing is unusual in cannabis. No dispensary can accept ordinary credit cards because the major card networks prohibit their systems from being used for a federally illegal product. Stores rely on cash, PIN debit, ACH, and cashless ATM transactions instead.

Cashless ATM is worth a special note, where available: the per-transaction fee is paid by the customer, and providers compete to win dispensary accounts by rebating part of that fee back to the store. For many operators, it is a small source of income rather than a cost, which is why it does not appear as an expense in the table below. This avenue is under ongoing pressure from the card networks, so its availability and economics vary. There are also likely debt service payments (interest and amortization) going out the door each month. Those will get paid before vendors, because no owners want to hand the keys to their personal equity to banks that financed them.

The critical feature of this list is that almost none of it moves with sales.

Security and compliance alone run $100,000 to $150,000 a year and are non-negotiable: armed guards, surveillance, armored transport, and seed-to-sale tracking cost the same whether the store has a busy month or a slow one. Rent, insurance, software, banking minimums, licensing, and debt service are equally fixed.

The only costs that truly shrink when sales fall are the product itself and, partially, staffing. This is why a smaller store does not enjoy proportionally smaller costs.

The fixed stack consumes a larger share of every dollar as revenue falls.

Can the Store Pay for the Inventory It Already Sold?

The cleanest way to see the squeeze is to follow one real obligation. At the start of the month, the store received $150,000 of product on 30-day terms, and that invoice is due at month-end. The question is simply whether the cash is there to pay it, first before taxes and then after.

The table below works through it, built on a full 108-line monthly expense schedule for a representative store, with California’s tax structure used for the two tax lines.

The schedule is a normalized monthly run-rate: annual costs such as audits, insurance, and license fees are spread evenly across the year rather than charged in the month they occur.

Table 1: Can the store pay its $150,000 vendor invoice at month-end? Representative store, $300K/month in sales (California tax structure)

Note: Follow the gross profit. The store sold $300,000 of product that cost $150,000, so it earned $150,000 in gross profit this month. Analysis A shows where most of it goes: $120,409 to operating the store, leaving $179,591 before tax. That looks like enough to cover the $150,000 invoice, but only by less than $30,000, under 10% of sales. Analysis B then takes the two taxes the operator genuinely bears, the local cannabis business tax and the 280E federal tax, totaling $37,500. That leaves $142,091 against a $150,000 invoice. The store is $7,909 short of paying the supplier that fronted its inventory. The gross profit did not vanish; it was consumed by fixed costs and taxes before the invoice that created it came due. Figures are illustrative model output built on a 108-line expense schedule, not measured actuals.

The Cash Flow Squeeze

This is the heart of the problem, and it has two layers. The first is structural: even before a dollar of tax, the cushion between cash on hand and the invoice due is thin, under 10% of sales. A dispensary cannot price its way out, because competition from the illicit and grey markets caps what a legal store can charge.

The second layer is tax. Add the two taxes the operator bears, and the thin cushion turns negative. What makes that tip invisible month to month is that the biggest single tax, the 280E federal liability, is an annual obligation that accrues continuously but is not billed every month; for illustration, we show it here as an even monthly slice, though in practice operators face it through quarterly estimates and year-end settlement.

An operator who does not set it aside can use that money to pay this month’s invoice and appear fine, while quietly falling behind on a tax that will come due. This is worth keeping in mind whenever you read that a majority of dispensaries are profitable.

Profitable on what basis?

A store that can only pay its vendors because it has not reserved its 280E tax, or has spent the sales and excise tax it is holding for the state, is not profitable in any sense that survives an audit. It is borrowing from the government and, when that runs out, from its suppliers by paying them late. Again, this is illustrative of a single store.

One honest qualification. This is a single representative month viewed in isolation, which is a deliberate stress lens rather than the full working-capital cycle. In practice, a store is also collecting cash on the prior month’s inventory while it sells this month’s, so steady-state timing is somewhat more forgiving than a one-month snapshot suggests.

But the structural point holds across the cycle: when fixed costs and taxes routinely consume the gross profit before the invoice that created it comes due, the gap does not disappear; it accumulates, and it is carried on the backs of suppliers.

How the Squeeze Moves with Sales and Margin

The $7,909 shortfall above belongs to one specific store: $300,000 a month at a 50% margin. A natural question is how sensitive that result is to the two inputs that vary most across the industry, monthly sales volume and gross margin.

The grid below answers it. Each cell shows the cash shortfall or surplus on the month-end vendor invoice at that combination of sales and margin.

The invoice itself moves with a margin, since a lower margin means a higher cost of goods to pay for.

Table 2: Shortfall (negative) or surplus (positive) on the month-end vendor invoice, by monthly sales and gross margin

Note: The base case is the pink cell. Negative cells, where the store cannot pay its invoice from that month’s cash, are shaded in red. The store clears its invoice only in the upper-right, where high volume meets high margin. Across most realistic combinations, the shortfall persists, and it deepens sharply toward the lower-left: a $250,000 store running a saturated-market 42% margin falls more than $39,000 short every month. Figures are illustrative model output, not measured actuals.

The pattern is the point. The shortfall is not an artifact of one unlucky store. It is the default condition for the typical operator, and only the best-positioned stores, those combining strong volume with the higher margins of a limited-license market, escape it. For reference, saturated markets typically run 38% to 42%, the national mid-range sits near 45% to 55%, and limited-license markets reach 58% to 62%.

The fixed nature of the cost stack is what makes this so unforgiving.

Of the roughly $120,000 in monthly operating costs, the overwhelming majority does not move with sales. Security, compliance, rent, insurance, software, debt service, and most of the payroll cost the same in a slow month as in a busy one.

Only a handful of lines, the product itself, card processing, packaging, and a few others, scale down when sales fall. So a good month does not help as much as it should, and a bad month is punishing, because almost nothing scales down with it.

Combined with a gross margin that competition holds near 50%, this is why even a tax-free version of this store barely breaks even.

It is the asymmetry at the center of the cannabis retail model, and it is the reason a slowdown anywhere in the chain is so quickly fatal.

The Two Pools That Are Easy to Spend

Two of the largest figures in the waterfall are not the operator’s money, yet they sit in the operator’s bank account for weeks at a time.

The first is the collected consumer tax. The dispensary gathers it at the register and holds it until the state’s remittance deadline. For those weeks, it looks and feels like available cash.

The second is the federal 280E liability.

Section 280E disallows every business deduction except the cost of goods sold for a federally illegal business. The effect is severe. For our $300,000-a-month store, gross profit is about $150,000 a month, or $1.8 million a year.

Federal tax is figured on that full gross profit, not on net income. At the 21% corporate rate, that is roughly $31,500 a month (this assumes a C-corporation; pass-through operators are taxed at individual rates up to 37%, so for many the burden is higher and the shortfall on the invoice is correspondingly worse), even though the store’s real economic profit is far smaller or negative.

Effective tax burdens under 280E commonly land between 60% and 80% of pre-tax income, against 25% to 35% for ordinary retail. Because that liability builds quietly and is often not set aside in cash, it too can feel like spendable working capital.

An operator who treats either pool as available money can cover payroll, fund marketing, or take an owner draw, and still appear profitable. When the tax deadlines and the vendor invoices arrive in the same month, the vendor, being last in line, is what goes unpaid.

And here is the reality: most operators do not reserve for 280E. They use this cash to pay vendors, but their Federal debt keeps climbing.

Will there be retroactive relief if cannabis is rescheduled from Schedule I to Schedule III? We shall see.

Why the Picture Differs by State

The 280E burden is not uniform across the country. Several states, including California and New York, do not conform to 280E for state income tax and let operators deduct ordinary expenses against state taxable income. An operator in a non-conforming state keeps more cash than an identical operator in a conforming state.

Add the wide variation in state and local consumer tax rates, and the same business model produces meaningfully different amounts of leftover cash depending on where it operates. A portion of the 280E burden can also be reduced through structuring: an IRC 471(c) election and disciplined cost allocation can legitimately expand what counts as cost of goods sold and recover part of it.

It is also worth noting that 280E itself is being challenged as this is written.

Federal rescheduling of cannabis to Schedule III, which would remove the 280E disallowance, has already taken effect for state-licensed medical operators (effective April 23, 2026), and an administrative hearing on extending that change to the adult-use market opened on June 29, 2026.

Should it succeed, the tax layer described here would ease. The deeper point of this paper survives that change: even with 280E set aside entirely, the thin structural margin shown above leaves a dispensary at barely break-even.

Following the Dollar Upstream

Whatever the dispensary actually pays its vendors becomes the distributor’s revenue. The distributor runs the same exercise: it pays its own payroll, rent, and costs, then pays the brands it bought from with whatever remains. The brand does the same with the manufacturer and cultivator, and so on down to packaging, hardware, testing, and transport.

As the dollar moves upstream, two things happen at once.

Each tier keeps a portion to cover its own costs, so the amount passed along shrinks at every step.

And margins thin as you move away from the retail counter, so the businesses furthest upstream are working with the least cushion.

Why a Slowdown Is Felt Upstream First

This is exactly where the shortfall above goes. Faced with a $150,000 invoice, it is $7,909 short on, the dispensary does the rational thing: it pays its vendors more slowly, stretching a 30-day invoice to 45 or 60 days. The dispensary itself is not in trouble. It is holding the cash. The strain travels to the businesses it owes.

The distributor, waiting on that payment, still has to make its own payroll and debt payments on time. With its incoming cash delayed, it must either dip into reserves or delay paying the brand.

The brand faces the same choice with the manufacturer, and the manufacturer with the cultivator. A delay that begins at the register is absorbed, tier by tier, by businesses that had nothing to do with causing it.

The result the model implies is counterintuitive but consistent: the party that slows down is the last to feel the pain, while the businesses upstream, with thinner margins and less room to absorb a gap, would feel it first and hardest.

This is a single-entity illustration rather than a measured study of the whole market, so it is best read as the mechanism by which a retail payment slowdown could surface as distress among cultivators and brands before it troubles the dispensary that started it, not as a claim about how often that occurs.

What the Money Trail Shows

• Most of a retail dollar is committed before it can reach a vendor. Payroll, rent, taxes, and debt come first; vendors are paid from the remainder.
• Some of the largest figures in the chain are tax money held temporarily. Collected consumer tax and unreserved 280E liability are easy to spend before they come due.
• 280E distorts cash flow more than the headline rate suggests, and it does so differently in conforming and non-conforming states.
• Cash shrinks and margins thin as you move upstream, so in this model, the same shortfall would land hardest on the businesses furthest from the register.
• A slowdown propagates in the direction of the product. Goods flow down to the customer; the cash problem flows back up.

Conclusion

The money does not vanish from the cannabis supply chain. It moves in a predictable order, and it gets held up at predictable points: behind two pools of spendable tax cash, and behind a vendor line that is always paid last.

Following a single retail dollar back up the chain shows that the businesses most exposed to a payment slowdown are frequently the ones that did the least to cause it. Understanding that path is the first step toward managing it.

Note from the author: Sources informing this paper include CohnReznick gross-margin analysis of public cannabis operators (2023), Northstar Financial Advisory dispensary margin benchmarks (2025), and AIM North America on seed-to-sale data (2022). California market-size and store-count figures are drawn from MJBiz Factbook 2026, California Department of Revenue cannabis tax filings, and state regulator active-license counts, as compiled by Cannabis Promotions, “California Cannabis Statistics 2026” (cannabispromotions.com/stats/states/california; last verified June 29, 2026). This paper is provided for educational purposes only.